EUVIMEDEUVIMED entdecken
Open Access

Formoterol alters chemokine expression and ameliorates pain behaviors after moderate spinal cord injury in female mice

Ingrid L Peterson, Natalie E Scholpa, Kiara J Bachtle, Jennifer B Frye, Sanna H Loppi, Austin D Thompson, Kristian Doyle, Tally Marie Largent-Milnes, Rick G Schnellmann

The Journal of Pharmacology and Experimental Therapeutics · 2025

DOI: 10.1124/jpet.124.002171 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pharmacology and Experimental Therapeutics, 2025. Verfasst von Ingrid L Peterson und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, College of Medicine, University of Arizona, Tucson, Arizona; Department of Pharmacology and Toxicology, College of Pharma…. Hauptthemen laut MEDLINE: Formoterol Fumarate, Spinal Cord Injuries, Chemokines, Behavior, Animal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCR NIH HHS, NIEHS NIH HHS, BLRD VA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Secondary spinal cord injury (SCI) is characterized by increased cytokines and chemokines at the site of injury that have been associated with the development of neuropathic pain. Nearly 80% of SCI patients report suffering from chronic pain, which is poorly managed with available analgesics. While treatment with the US Food and Drug Administration-approved β2-adrenergic receptor agonist formoterol improves various aspects of recovery post-SCI in vivo, its effects on cytokines, chemokines, and neuropathic pain remain unknown. Female mice were subjected to moderate (60 kilodynes [kdyn]) or severe (80 kdyn) SCI followed by daily treatment with vehicle or formoterol (0.3 mg/kg, i.p.) beginning 8 hours after injury. The expression of proinflammatory cytokines/chemokines, such as interferon gamma-induced protein 10, macrophage inflammatory protein 1a, monocyte chemoattractant protein 1, B-cell attracting chemokine 1, and nuclear factor kappa-light-chain-enhancer of activated B-cells, was increased in the injury site of vehicle-treated mice 24 hours post-SCI, which was ameliorated with formoterol treatment, regardless of injury severity. Thermal hyperalgesia and mechanical allodynia, as measured by Hargreaves infrared apparatus and von Frey filaments, respectively, were assessed prior to SCI and then weekly beginning 21 days post-injury (DPI). While all injured mice exhibited decreased withdrawal latency following thermal stimulation compared with baseline, formoterol treatment reduced this response ∼15% by 35 DPI. Vehicle-treated mice displayed significant mechanical allodynia, as evidenced by a 55% decrease in withdrawal threshold from baseline. In contrast, mice treated with formoterol maintained a consistent withdrawal time at all times tested. These data indicate that formoterol reduces inflammation post-SCI, likely contributing to mitigation of neuropathic pain and further supporting the therapeutic potential of this treatment strategy. SIGNIFICANCE STATEMENT: Chronic pain is a detrimental consequence of spinal cord injury (SCI). We show that treatment with the US Food and Drug Administration-approved drug formoterol after SCI decreases injury site proinflammatory chemo-/cytokines and alters markers of glial cell activation and infiltration. Additionally, formoterol treatment improves locomotor function and body composition, and decreases lesion volume. Finally, formoterol treatment decreased mechanical allodynia and thermal hyperalgesia post-SCI. These data are suggestive of the mechanism of formoterol-induced recovery, and further indicate its potential as a therapeutic strategy for SCI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Formoterol FumarateSpinal Cord InjuriesChemokinesBehavior, AnimalAdrenergic beta-2 Receptor AgonistsAnimalsFemaleMiceMice, Inbred C57BLNeuralgia

Stichwörter der Autor:innen

FormoterolMitochondrial biogenesisNeuroinflammationPainSpinal cord injury

Substanzen

Formoterol FumarateChemokinesAdrenergic beta-2 Receptor Agonists

Autor:innen und Institutionen

  • Department of Pharmacology, College of Medicine, University of Arizona, Tucson, Arizona; Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona.
  • Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona; Southern Arizona VA Health Care System, Tucson, Arizona. Electronic address: nscholpa@arizona.edu.
  • Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona.
  • Department of Immunobiology, College of Medicine, University of Arizona, Tucson, Arizona.
  • Southern Arizona VA Health Care System, Tucson, Arizona; Department of Immunobiology, College of Medicine, University of Arizona, Tucson, Arizona.
  • Department of Pharmacology, College of Medicine, University of Arizona, Tucson, Arizona.

Förderung

  • NIDCR NIH HHS
  • NIEHS NIH HHS
  • BLRD VA
  • NHLBI NIH HHS
  • NINDS NIH HHS

Zitieren

APA

Peterson, I. L., Scholpa, N. E., Bachtle, K. J., Frye, J. B., Loppi, S. H., Thompson, A. D., Doyle, K., Largent-Milnes, T. M., & Schnellmann, R. G. (2025). Formoterol alters chemokine expression and ameliorates pain behaviors after moderate spinal cord injury in female mice. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1124/jpet.124.002171

Vancouver

Peterson IL, Scholpa NE, Bachtle KJ, Frye JB, Loppi SH, Thompson AD, et al. Formoterol alters chemokine expression and ameliorates pain behaviors after moderate spinal cord injury in female mice. The Journal of Pharmacology and Experimental Therapeutics. 2025. doi:10.1124/jpet.124.002171

BibTeX
@article{Peterson2025,
  author = {Peterson, Ingrid L and Scholpa, Natalie E and Bachtle, Kiara J and Frye, Jennifer B and Loppi, Sanna H and Thompson, Austin D and Doyle, Kristian and Largent-Milnes, Tally Marie and Schnellmann, Rick G},
  title = {Formoterol alters chemokine expression and ameliorates pain behaviors after moderate spinal cord injury in female mice},
  journal = {The Journal of Pharmacology and Experimental Therapeutics},
  year = {2025},
  doi = {10.1124/jpet.124.002171}
}
Kostenlos starten →